Supplementary
: MCF-7, MDA-MB-231, and MDA-MB-468 cells were cultured and exposed to fulvestrant at different concentrations. Proliferation was measured as described in the materials section. *P<0.05 and ***P<0.001 compared to controls, n=8 in each group. Bars represent mean±SEM. The control group represents the normalized absorbance of unexposed (hormone media alone) cells.
Supplementary Figure S2:
Oophorectomized Balb/C-nu/nu mice were supplemented with physiological levels of estradiol (E2) and injected with MCF-7 or MDA-MB-231 cells in the mammary fat pad. Tumor sections from the different treatment groups were stained for ERβ (clone 57/3) and quantified as described in Materials and Methods. A. At similar tumor sizes, MCF-7 tumors were treated as follows; one group continued with E2 treatment and the other group received an additional tamoxifen (Tam) treatment (1 mg/mouse every second day s.c.), fulvestant (Fulv) (5mg/mouse twice weekly s.c.), or their combination. B. MDA-MB-231 tumors were treated as follows; one group were untreated, one group received tamoxifen treatment (1 mg/mouse every second day s.c.) and one group received fulvestant (5mg/mouse twice weekly s.c.). Representative sections from each treatment group are shown. Scale bars=50 µm. ***P<0.001 compared to the control group n=9 in each group. Bars represent mean±SEM.
